Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

Skin conditions can signal diabetes and insulin resistance.

Oxidative stress, not insulin resistance, is linked to diffuse hair loss.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Understanding proteins linked to PCOS symptoms can improve diagnosis and treatment.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

No clear link between pilonidal sinus disease and polycystic ovary syndrome was found.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Hair loss linked to higher heart disease risk in both men and women.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.